About Us
Part of the global pharmaceutical UBI Group, UBI Pharma consolidates the Group’s established values and builds a strong foundation of technology and production in the manufacture of pharmaceuticals, providing world-class pharmaceutical quality products. We develop innovative products such as non-monoclonal antibodies, novel small molecule drugs, and specialty injectables.
Board of Directors

Director
Shih-Chia Lin
- Education:
- M.S., Institute of Health and Welfare of National Yang Ming University
- Experience:
- Member of the 8th Legislative Yuan
- Director, First Venture Capital Co., Ltd.
- Director, Formosa Television Co., Ltd.
- Chairman, Peng Wan Ru Foundation
- CEO, Tai An Technologies Corporation
- Current Affiliation:
- Director and General Manager, Locus Cell Co., Ltd.
- Director, Taimed Biologics Inc.
- Director, Genomics Bioscience & Technology Co., Ltd.
- Director, Eminent II Venture Capital Corporation
- Director, Eminent III Venture Capital Corporation
- Director, Syncore Biotechnology Co., Ltd.
- CEO, Foundation of Medical Professionals Alliance in Taiwan
UBI Pharma Inc.
No.45, Guangfu N. Rd., Hukou Township, Hsinchu County 303036, Taiwan (R.O.C.)
- Tel:+886-3-5977676
- Fax:+886-3-5981173